208 related articles for article (PubMed ID: 21872588)
1. Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia.
Schmidt RE; Feng D; Wang Q; Green KG; Snipes LL; Yamin M; Brines M
Exp Neurol; 2011 Dec; 232(2):126-35. PubMed ID: 21872588
[TBL] [Abstract][Full Text] [Related]
2. Neuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic ganglia.
Schmidt RE; Green KG; Snipes LL; Feng D
Exp Neurol; 2009 Mar; 216(1):207-18. PubMed ID: 19111542
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.
Schmidt RE; Green KG; Feng D; Dorsey DA; Parvin CA; Lee JM; Xiao Q; Brines M
Exp Neurol; 2008 Jan; 209(1):161-70. PubMed ID: 17967455
[TBL] [Abstract][Full Text] [Related]
4. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Frederick KE; Parvin CA; Plurad SB; Levisetti MG
Am J Pathol; 2003 Nov; 163(5):2077-91. PubMed ID: 14578206
[TBL] [Abstract][Full Text] [Related]
5. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
[TBL] [Abstract][Full Text] [Related]
6. Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Escandon E
J Neuropathol Exp Neurol; 2001 Mar; 60(3):263-73. PubMed ID: 11245210
[TBL] [Abstract][Full Text] [Related]
7. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
8. Impaired Nociception in the Diabetic
Vastani N; Guenther F; Gentry C; Austin AL; King AJ; Bevan S; Andersson DA
Diabetes; 2018 Aug; 67(8):1650-1662. PubMed ID: 29875100
[TBL] [Abstract][Full Text] [Related]
9. Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.
Obrosova IG; Stavniichuk R; Drel VR; Shevalye H; Vareniuk I; Nadler JL; Schmidt RE
Am J Pathol; 2010 Sep; 177(3):1436-47. PubMed ID: 20724598
[TBL] [Abstract][Full Text] [Related]
10. Altered bone microarchitecture in a type 1 diabetes mouse model Ins2
Carvalho FR; Calado SM; Silva GA; Diogo GS; Moreira da Silva J; Reis RL; Cancela ML; Gavaia PJ
J Cell Physiol; 2019 Jun; 234(6):9338-9350. PubMed ID: 30317631
[TBL] [Abstract][Full Text] [Related]
11. Synaptic ultrastructural alterations anticipate the development of neuroaxonal dystrophy in sympathetic ganglia of aged and diabetic mice.
Schmidt RE; Parvin CA; Green KG
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1166-86. PubMed ID: 19018240
[TBL] [Abstract][Full Text] [Related]
12. Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.
Jun JY; Ma Z; Pyla R; Segar L
Atherosclerosis; 2012 Dec; 225(2):341-7. PubMed ID: 23099119
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
14. The effect of pancreatic islet transplantation and insulin therapy on neuroaxonal dystrophy in sympathetic autonomic ganglia of chronic streptozocin-diabetic rats.
Schmidt RE; Plurad SB; Olack BJ; Scharp DW
Brain Res; 1989 Sep; 497(2):393-8. PubMed ID: 2510903
[TBL] [Abstract][Full Text] [Related]
15. Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Reiser KM; Williamson JR; Tilton RG
Diabetes; 1996 Mar; 45(3):284-90. PubMed ID: 8593931
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Miller MS
Am J Pathol; 1999 Nov; 155(5):1651-60. PubMed ID: 10550321
[TBL] [Abstract][Full Text] [Related]
17. Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice.
de Preux Charles AS; Verdier V; Zenker J; Peter B; Médard JJ; Kuntzer T; Beckmann JS; Bergmann S; Chrast R
PLoS One; 2010 May; 5(5):e10832. PubMed ID: 20520806
[TBL] [Abstract][Full Text] [Related]
18. Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice.
Park HJ; Zhang Y; Du C; Welzig CM; Madias C; Aronovitz MJ; Georgescu SP; Naggar I; Wang B; Kim YB; Blaustein RO; Karas RH; Liao R; Mathews CE; Galper JB
Circ Res; 2009 Jul; 105(3):287-94. PubMed ID: 19423844
[TBL] [Abstract][Full Text] [Related]
19. The effects of intermittent insulin therapy on the autonomic neuropathy in the streptozotocin diabetic rat.
Monckton G; Pehowich E
Can J Neurol Sci; 1982 May; 9(2):79-84. PubMed ID: 7049342
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Peterson RG
Am J Pathol; 2003 Jul; 163(1):21-8. PubMed ID: 12819007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
